Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pitfalls of drug development: lessons learned from trials of denufosol in cystic fibrosis.

The Journal of pediatrics - 1 Apr 2013

Moss Richard B

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clinical Trials as Topic
Share to Cystic Fibrosis
Share to Cystic Fibrosis Transmembrane Conductance Regulator
Share to Drug Design

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Industry

Share to Research Design

Share to Sputum

Share to Uridine

Source

Identifiers

PMID: 23290508
DOI: 10.1016/j.jpeds.2012.11.034

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pitfalls of drug development: lessons learned from trials of denufosol in cystic fibrosis.PMID 23290508Read ↗

Small molecule drugs in cystic fibrosis.Semantic proximity Read ↗

SIMPLIFYing cystic fibrosis treatment in a post-modulator era.Semantic proximity Read ↗

Cystic fibrosis: What next for the "wonder drug" Kaftrio?Semantic proximity Read ↗

Clinical trial research in focus: ensuring new cystic fibrosis drugs fulfil their potential.Semantic proximity Read ↗

Novel pharmacologic therapies for cystic fibrosis.Semantic proximity Read ↗

Trials and tribulations of highly effective modulator therapies in cystic fibrosis.Semantic proximity Read ↗

Real Life With Tezacaftor and Ivacaftor in Adult Patients With Cystic Fibrosis: Spanish Multicenter Study.Semantic proximity Read ↗

Elexacaftor/Tezacaftor/Ivacaftor Effectiveness in N1303K Variant in Adult People With Cystic Fibrosis.Semantic proximity Read ↗

New Pharmacological Approaches to Treat Patients with Cystic Fibrosis with Nonsense Mutations.Semantic proximity Read ↗

Gentamicin in pharmacogenetic approach to treatment of cystic fibrosis.Semantic proximity Read ↗

The effectiveness and value of novel treatments for cystic fibrosis.Semantic proximity Read ↗

ELX/TEZ/IVA use in cystic fibrosis liver disease: Is the perspective of improved lung function worth the risk?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.